American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2021, 9(1), 71-74
DOI: 10.12691/ajmcr-9-1-18
Open AccessCase Report

Adult Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation: Case Report with Molecular Analysis

Simin Laiq1, Jaragh M2, Ginsberg H3, and David G Munoz2

1Histopathology Department, Directorate General of Khoula Hospital, Muscat, Oman

2Division of Pathology, St. Michael’s Hospital, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

3Division of Neurosurgery, St. Michael’s Hospital, Department of Surgery, Toronto, Ontario, Canada

Pub. Date: November 12, 2020

Cite this paper:
Simin Laiq, Jaragh M, Ginsberg H and David G Munoz. Adult Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation: Case Report with Molecular Analysis. American Journal of Medical Case Reports. 2021; 9(1):71-74. doi: 10.12691/ajmcr-9-1-18

Abstract

Medulloblastoma with myogenic differentiation (MMD), previously termed medullomyoblastoma, is a distinctive subtype of medulloblastoma. It is an uncommon neoplasm in children and very rare in adults, with oldest reported case being 49-years of age. We present a case of large cell/anaplastic medulloblastoma with myogenic differentiation arising in the right cerebellar hemisphere of a 54-year-old man treated by surgical resection and radiotherapy. Despite C-MYC amplification in the tumor, he survived tumor-free for nearly 2 years (726 days), which greatly exceeded the expected total survival. His death was attributed to complications of treatment rather than recurrence.

Keywords:
Large cell/anaplastic medulloblastoma with myogenic differentiation medullomyoblastoma cerebellum adult C-MYC amplification

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Louis DN et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2): 97-109.
 
[2]  Schiffer D, Giordana MT, Pezzotta S, Pezzulo T, Vigliani MC. (1992). Medullomyoblastoma: report of two cases. Child’s Nerv Syst 8: 268-272.
 
[3]  Ke, C.-S & Deng, Z.-D & Lei, T. & Zeng, L.-C & Wu, S.-M & Wan, J.. (2008). Medullomyoblastoma: Report of an adult case and review of literatures. Chinese Journal of Contemporary Neurology and Neurosurgery. 8. 567-571.
 
[4]  Marinesco G, Goldstein M. (1933). Sur une forme anatomique, non encore decrite, de medulloblastome: Medullomyoblastome. Ann. Anat. Pathol 10: 513-525.
 
[5]  Smith T, Davidson R. (1984). Medullomyoblastoma: A histologic, immunohistochemical, and ultrastructural study. Cancer 54: 323-332
 
[6]  Smith TW, Davidson RI. Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study. Cancer 1984; 54: 323-32.
 
[7]  Helton KJ et al (2004). Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature. Cancer 101(6): 1445-1454.
 
[8]  Bartlett F, Kortmanny R, Saran F. (2013) Medulloblastoma. Clinical oncology 25: 36-45.
 
[9]  Yoshino S, Etoh Y, Konishi Y, Iwaki T, Okada H, Nishida T, Imai T, Isobe K, Itoh S, Tamiya T (2011) A case of medullomyoblastoma. Pediatrics International. 53(3): 399-402.
 
[10]  Rattenberry W, McDonough C H, Burger P C, Cohen K J (2011) Medulloblastoma with myogenic differentiation: long-term survival in a patient treated with aggressive combination therapy and autologous stem cell transplantation. J Neurooncol 105: 659-662.